We are pleased to announce that Joan Font-Burgada has won the 2018 IRB Barcelona Alumni of Excellence Award. This distinction, which is currently in its third edition and is supported by Eppendorf, acknowledges outstanding contributions to science and the scientific community made by young researchers who have completed a significant part of their training and careers at IRB Barcelona.
The IRB Barcelona Alumni of Excellence Award is given with the support of Eppendorf.
More information about the IRB Barcelona Alumni of Excellence Awards here
Joan Font-Burgada (Caldes de Montbui, Barcelona, 1977), PhD researcher in the Cell and Developmental Biology Program of IRB Barcelona (2006-2010), under the supervision of Dr. Ferran Azorín. Postdoctoral fellow at the University of California, San Diego in Dr. Michael Karin's group (Department of Pharmacology). Currently Assistant Professor at the Fox Chase Cancer Center in Philadelphia.
Joan is recognized “for his important contributions to understand the development of cancer, in particular, why cancers evolve with mutations that are poorly immunogenic, and also for the identification of special hepatic reparative cells with low propensity to produce cancer”.
PhD researcher in IRB Barcelona’s Complex Metabolic Diseases and Mitochondria Lab (2003-2009), Postdoctoral Fellow in Molecular Medicine at Boston University School of Medicine, Department of Medicine, Boston Medical Center (Boston, USA), since 2015, and since 2015 Assistant Professor in-Residence, step II, at David Geffen School of Medicine at UCLA (Los Angeles, USA).
Marc is recognized "for his important contributions to mitochondrial biology, in particular the study of the functional relationships between organelle morphology and cellular energetics, and the identification of ABCB10 as the first mitochondrial ATP transporter essential in oxidative stress protection”.
The IRB Barcelona Alumni of Excellence Award ceremony was held on 5 May 2017.
PhD and postdoctoral research in IRB Barcelona's Metabolic Engineering and Diabetes Therapy Lab (2003-2008).
Group Leader since 2013 at the CECAD-Cluster of Excellence in Cologne, Germany, where he received an ERC Starting Grant.
David is recognized for his “insight, originality and courage to start interdisciplinary and innovative scientific approaches. He has demonstrated an ability to conduct ground-breaking research throughout his career with outstanding scientific achievements on subjects as diverse as neurodegeneration, proteostasis, aging and stem cell biology.”
The IRB Barcelona Alumni of Excellence Award ceremony took place on 16 September 2016.